Related Experiment Video
Updated: Mar 16, 2026

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
[Short version of the German S3 guideline for bladder cancer]
M Retz1, J E Gschwend2, P Maisch2
1Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland. margitta.retz@tum.de.
Abstract:
Urinary bladder cancer is the second most common cancer of the urogenital system. The Guideline Program in Oncology (Leitlinienprogramm Onkologie) of the Association of the Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF), the German Cancer Society (Deutsche Krebsgesellschaft) and the German Cancer Aid (Deutsche Krebshilfe) as well as 31 different medical societies have developed the first interdisciplinary, evidence-based German guideline for bladder cancer. This short version presents the resulting series of diagnostic and therapeutic recommendations which were based on a systematic literature search and approved by a team of bladder cancer experts. The full version is available under http://leitlinienprogramm-onkologie.de/ .
Insights
This summary outlines the first German evidence-based guideline for urinary bladder cancer, offering diagnostic and therapeutic recommendations. It is developed by leading medical societies for improved bladder cancer care.
Area of Science:
- Oncology
- Urology
Background:
- Urinary bladder cancer is a prevalent malignancy within the urogenital system.
- The development of comprehensive guidelines is crucial for standardized patient care.
Purpose of the Study:
- To present the key diagnostic and therapeutic recommendations from the first interdisciplinary, evidence-based German guideline for bladder cancer.
- To provide a concise overview of expert-approved strategies for managing bladder cancer.
Main Methods:
- Systematic literature search to identify relevant evidence.
- Consensus development by a multidisciplinary team of bladder cancer experts.
- Approval by major German medical societies and oncology programs.
Main Results:
- The guideline offers a series of evidence-based recommendations for the diagnosis and treatment of urinary bladder cancer.
- Key aspects of diagnostic workup and therapeutic interventions are detailed.
Conclusions:
- The guideline provides a unified, evidence-based approach to bladder cancer management in Germany.
- This resource aims to improve the quality of care for patients with bladder cancer.
More Related Videos
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi III: Medical Management
Urologic Endoscopic Procedure: Cystoscopic Examination
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies III: Computed Tomography
Urinary Tract Calculi V: Nursing Management